Prosecution Insights
Last updated: April 19, 2026

Genexa Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18619076 SOLID PHARMACEUTICAL TABLET STEVENS, MARK V 1613 Non-Final OA Mar 27, 2024
18608901 DEXTROMETHORPHAN AND GUAIFENESIN SYRUP FORMULATION ALAWADI, SARAH 1619 Non-Final OA Mar 18, 2024
18201375 SYRUP FORMULATION OR SUSPENSION ALAWADI, SARAH 1619 Non-Final OA May 24, 2023
18057119 SOLID PHARMACEUTICAL TABLET TRAN, SUSAN T 1615 Final Rejection Nov 18, 2022

Managing Genexa Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month